NM_014979.4:c.581-15486T>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_014979.4(SV2C):c.581-15486T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.593 in 152,026 control chromosomes in the GnomAD database, including 28,743 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.59 ( 28743 hom., cov: 32)
Consequence
SV2C
NM_014979.4 intron
NM_014979.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0740
Publications
4 publications found
Genes affected
SV2C (HGNC:30670): (synaptic vesicle glycoprotein 2C) Predicted to enable transmembrane transporter activity. Predicted to be involved in chemical synaptic transmission; neurotransmitter transport; and transmembrane transport. Predicted to be located in plasma membrane and synaptic vesicle. Predicted to be active in neuron projection and synaptic vesicle membrane. Predicted to be integral component of synaptic vesicle membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.891 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.593 AC: 90006AN: 151908Hom.: 28686 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
90006
AN:
151908
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.593 AC: 90121AN: 152026Hom.: 28743 Cov.: 32 AF XY: 0.597 AC XY: 44340AN XY: 74272 show subpopulations
GnomAD4 genome
AF:
AC:
90121
AN:
152026
Hom.:
Cov.:
32
AF XY:
AC XY:
44340
AN XY:
74272
show subpopulations
African (AFR)
AF:
AC:
32950
AN:
41470
American (AMR)
AF:
AC:
9873
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
1687
AN:
3470
East Asian (EAS)
AF:
AC:
4724
AN:
5176
South Asian (SAS)
AF:
AC:
2840
AN:
4808
European-Finnish (FIN)
AF:
AC:
4964
AN:
10552
Middle Eastern (MID)
AF:
AC:
121
AN:
294
European-Non Finnish (NFE)
AF:
AC:
31357
AN:
67954
Other (OTH)
AF:
AC:
1196
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1678
3356
5035
6713
8391
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
734
1468
2202
2936
3670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2631
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.